Regardless of adherence to weekly Wegovy (semaglutide) injections, adults with obesity who received a higher dose of the medication lost an average of 18.7% of their body weight. More than 1,400 ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Here is more information on Wegovy, how to decide if it’s right for you, and what you need to know about the Wegovy ...

Novo Nordisk said that patients taking a higher dose of its blockbuster Wegovy obesity shot lost more weight than those on a lower dose without experiencing an increase in side effects ...

Under medical supervision, GLP-1 agonists often lead to safe, sustainable weight loss, as noted in clinical reviews ... at each of these medications. Wegovy is a GLP-1 agonist containing ...

Patients treated with semaglutide 7.2 mg achieved a 20.7 ... a once-daily oral GLP-1 receptor agonist for weight loss, by early 2026. (Becker's Hospital Review) An international panel of 31 ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

WASHINGTON — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers ...